Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2018-08-15
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of Irinotecan in combination
with FOLFOX+Bevacizumab versus FOLFOX+Bevacizumab alone in the first-line treatment of
patients with metastatic colorectal cancer.